The average selling price for VALSALVA in Denmark grew in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the VALSALVA device in Denmark can be viewed in GlobalData’s micro pricing report. Buy the report here.
The VALSALVA is sold by Livanova in the Tissue Sutured Aortic Valve Replacements market. Tissue sutured aortic valve replacements are used for replacement of the aortic heart valve using a biological prosthesis. They are made from a stented tissue valve that can be compressed to become smaller. The valve does not require sutures to stay in place.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Livanova’ Tissue Sutured Aortic Valve Replacements device pricing in Denmark, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.